C

Choksi Laboratories Ltd
BSE:526546

Watchlist Manager
Choksi Laboratories Ltd
BSE:526546
Watchlist
Price: 115.25 INR 1.77% Market Closed
Market Cap: ₹803.3m

Relative Value

526546 doesn't have a meaningful market cap.

The Relative Value of one CHOKSILA stock under the Base Case scenario is hidden INR. Compared to the current market price of 115.25 INR, Choksi Laboratories Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CHOKSILA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

CHOKSILA Competitors Multiples
Choksi Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Choksi Laboratories Ltd
BSE:526546
788.8m INR 1.8 48.5 8 18.5
UK
Relx PLC
LSE:REL
49.3B GBP 5.1 25.1 18 18.5
CA
Thomson Reuters Corp
TSX:TRI
71.1B CAD 7 29.4 12.5 17.6
UK
IHS Markit Ltd
F:0M3
37.9B EUR 9.5 36.5 31.2 46.7
IE
Experian PLC
LSE:EXPN
24.9B GBP 4.1 24.2 18 25.4
US
Verisk Analytics Inc
NASDAQ:VRSK
30.4B USD 10 32.9 18.8 23.3
US
CoStar Group Inc
NASDAQ:CSGP
28.2B USD 9.2 1 390.4 194.7 -336.5
US
Equifax Inc
NYSE:EFX
25.2B USD 4.2 38.3 15.3 24.4
US
Leidos Holdings Inc
NYSE:LDOS
23.9B USD 1.4 17 11.8 13.5
CH
SGS SA
SIX:SGSN
17.9B CHF 2.6 28.6 20.8 20.8
NL
Wolters Kluwer NV
AEX:WKL
19.1B EUR 3.1 16.8 11.3 14.9
P/E Multiple
Earnings Growth PEG
IN
C
Choksi Laboratories Ltd
BSE:526546
Average P/E: 153.4
48.5
N/A N/A
UK
Relx PLC
LSE:REL
25.1
14%
1.8
CA
Thomson Reuters Corp
TSX:TRI
29.4
1%
29.4
UK
I
IHS Markit Ltd
F:0M3
36.5
N/A N/A
IE
Experian PLC
LSE:EXPN
24.2
21%
1.2
US
Verisk Analytics Inc
NASDAQ:VRSK
32.9
8%
4.1
US
CoStar Group Inc
NASDAQ:CSGP
1 390.4
80%
17.4
US
Equifax Inc
NYSE:EFX
38.3
30%
1.3
US
Leidos Holdings Inc
NYSE:LDOS
17
10%
1.7
CH
SGS SA
SIX:SGSN
28.6
15%
1.9
NL
Wolters Kluwer NV
AEX:WKL
16.8
11%
1.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
C
Choksi Laboratories Ltd
BSE:526546
Average EV/EBITDA: 32.8
8
N/A N/A
UK
Relx PLC
LSE:REL
18
16%
1.1
CA
Thomson Reuters Corp
TSX:TRI
12.5
7%
1.8
UK
I
IHS Markit Ltd
F:0M3
31.2
N/A N/A
IE
Experian PLC
LSE:EXPN
18
10%
1.8
US
Verisk Analytics Inc
NASDAQ:VRSK
18.8
10%
1.9
US
CoStar Group Inc
NASDAQ:CSGP
194.7
92%
2.1
US
Equifax Inc
NYSE:EFX
15.3
12%
1.3
US
Leidos Holdings Inc
NYSE:LDOS
11.8
6%
2
CH
SGS SA
SIX:SGSN
20.8
10%
2.1
NL
Wolters Kluwer NV
AEX:WKL
11.3
7%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
C
Choksi Laboratories Ltd
BSE:526546
Average EV/EBIT: 22.4
18.5
N/A N/A
UK
Relx PLC
LSE:REL
18.5
11%
1.7
CA
Thomson Reuters Corp
TSX:TRI
17.6
10%
1.8
UK
I
IHS Markit Ltd
F:0M3
46.7
N/A N/A
IE
Experian PLC
LSE:EXPN
25.4
14%
1.8
US
Verisk Analytics Inc
NASDAQ:VRSK
23.3
11%
2.1
US
CoStar Group Inc
NASDAQ:CSGP
Negative Multiple: -336.5
403%
N/A
US
Equifax Inc
NYSE:EFX
24.4
18%
1.4
US
Leidos Holdings Inc
NYSE:LDOS
13.5
8%
1.7
CH
SGS SA
SIX:SGSN
20.8
13%
1.6
NL
Wolters Kluwer NV
AEX:WKL
14.9
9%
1.7